Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela B Smith

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
The Journal of Urology|January 5, 2022
Reply by AuthorsSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
The Journal of Urology|December 17, 2021
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final ReportSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
Urologic Oncology|December 13, 2023
Interruptions in bladder cancer care during the COVID-19 public health emergencyJohn L Gore, Kristin Follmer, Jason Reynolds, et al.
Cancer Cell|August 27, 2014
The somatic genomic landscape of chromophobe renal cell carcinomaCaleb F Davis, Christopher J Ricketts, Min Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
The Journal of Urology|January 5, 2022
Reply by AuthorsSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
The Journal of Urology|December 17, 2021
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final ReportSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer<sup></sup>Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder CancerElaine Chang, Noah M Hahn, Seth P Lerner, et al.
Urologic Oncology|December 13, 2023
Interruptions in bladder cancer care during the COVID-19 public health emergencyJohn L Gore, Kristin Follmer, Jason Reynolds, et al.
Cancer Cell|August 27, 2014
The somatic genomic landscape of chromophobe renal cell carcinomaCaleb F Davis, Christopher J Ricketts, Min Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder CancerJohn L Gore, Erika M Wolff, Michael G Nash, et al.
Pageof 17